Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group-Reference-Cited by-同舟云学术

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

Published:2018-01 Issue:1 Volume:19 Page:e33-e42
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Alexander Brian M,Brown Paul D,Ahluwalia Manmeet S,Aoyama Hidefumi,Baumert Brigitta G,Chang Susan M,Gaspar Laurie E,Kalkanis Steven N,Macdonald David R,Mehta Minesh P,Soffietti Riccardo,Suh John H,van den Bent Martin J,Vogelbaum Michael A,Wefel Jeffrey S,Lee Eudocia Q,Wen Patrick Y

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Epidemiology of brain metastases;Nayak;Curr Oncol Rep,2011

2. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group;Lin;Lancet Oncol,2013

3. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group;Lin;Lancet Oncol,2013

4. Response assessment criteria for brain metastases: proposal from the RANO group;Lin;Lancet Oncol,2015

5. Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group;Camidge;Lancet Oncol,2018

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with stereotactic radiosurgery;Physics and Imaging in Radiation Oncology;2024-07

3. Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course;Advances in Radiation Oncology;2024-06

4. Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060;JTO Clinical and Research Reports;2024-04

5. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas;Current Neurology and Neuroscience Reports;2024-01-03